BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, August 2, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Jan. 26, 2022

Jan. 26, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Achieve, Arcturus, Athira, Biomea, Biontech, Cartesian, Cerevance, Checkpoint, Chiesi, Cindome, Daewoong, Deciphera, ITM, Mina, Pfizer, Remegen, Sierra.
Read More

In the clinic for Jan. 18-24, 2022

Jan. 25, 2022
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Angel, Anges, Aslan, Calcimedica, Clover, Corvus, Cstone, Eisai, Elpiscience, Eqrx, HDT, Hinova, Hutchmed, I-Mab, Immvira, Keymed, Lynk, Merck, Recce, Resverlogix, Revelation, Revive, Sciwind, Sorrento, Vasomune.
Read More

In the clinic for Jan. 25, 2022

Jan. 25, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Intersect ENT.
Read More

In the clinic for Jan. 25, 2022

Jan. 25, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Arcturus, Ascletis, Basilea, Beigene, Biolinerx, Biothera, Connect, Erytech, Gensight, Harbour, Horizon, Innovent, Kalvista, Kintor, Lyra, Maat, Mediwound, Mirati, Mybiotics, Obi, Orchard, Panbela, SAB, Todos, Verona.
Read More

In the clinic for Jan. 24, 2022

Jan. 24, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Veracyte.
Read More

In the clinic for Jan. 24, 2022

Jan. 24, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aslan, Clover, Opiant, Provention, UCB.
Read More

In the clinic for Jan. 21, 2022

Jan. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Braintale.
Read More

In the clinic for Jan. 21, 2022

Jan. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arecor, Biovie, Calcimedica, Elpiscience, Hinova, Hutchmed, Idorsia, Infant Bacterial, Intelgenx, Merck, Oncolytic, Revelation, Seres, Sorrento, Vigeo, Xilio, Zealand.
Read More

In the clinic for Jan. 20, 2022

Jan. 20, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neovasc.
Read More

In the clinic for Jan. 20, 2022

Jan. 20, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cstone, Eisai, Eqrx, Essa, Immix, Immvira, Lynk, Recce, Revive, Sanofi, Vyne.


Read More
Previous 1 2 … 208 209 210 211 212 213 214 215 216 … 330 331 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Jingxin discloses new muscarinic and sigma receptor agonists

    BioWorld Science
    Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing